Related Experiment Video
Updated: Jan 18, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Tumor-associated neutrophils promote breast cancer progression via RLN2/RXFP1-C6orf99-STAT3 axis
Shujing Wang1, Youjing Sheng2, Wuqin Xu3
1Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, PR China.
Abstract:
Tumor-associated neutrophils (TANs) play a critical role in breast cancer progression. This study demonstrated that high CD66b+ TANs infiltration correlated with poor disease-free survival (DFS) and promoted proliferation, migration, and invasion of breast cancer cells in vitro. Conversely, the immune-related long non-coding RNA C6orf99 was downregulated in breast cancer and associated with favorable DFS. Functional assays revealed that C6orf99 suppressed tumor growth and metastasis by inhibiting STAT3 phosphorylation. Mechanistically, TANs-derived RLN2 downregulated C6orf99 through the RXFP1 receptor, thereby phosphorylating STAT3. Clinically, C6orf99 expression negatively correlated with TANs density and phospho-STAT3 levels in breast cancer tissues. These findings highlight the critical role of TANs in breast cancer progression through the regulation of C6orf99, offering potential therapeutic targets to disrupt the RLN2/RXFP1-C6orf99-STAT3 axis in breast cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Nucleolus
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

